Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial-Reference-Cited by-同舟云学术

Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial

Published:2019-11-19 Issue:12 Volume:110 Page:3650-3662
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Akazawa Yu¹²^ORCID,Hosono Ako³,Yoshikawa Toshiaki¹,Kaneda Hide⁴,Nitani Chika⁵,Hara Junichi⁵,Kinoshita Yoshiaki⁶,Kohashi Kenichi⁷,Manabe Atsushi⁸,Fukutani Miki⁹,Wakabayashi Masashi⁹,Sato Akihiro⁹,Shoda Kayoko¹,Shimomura Manami¹,Mizuno Shoichi¹,Nakamoto Yasunari²,Nakatsura Tetsuya¹^ORCID

Affiliation:

1. Division of Cancer Immunotherapy Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan

2. Second Department of Internal Medicine Faculty of Medical Sciences University of Fukui Eiheiji‐cho Japan

3. Division of Pediatric Oncology National Cancer Center Hospital East Kashiwa Japan

4. Division of Pediatric Oncology National Cancer Center Hospital Tokyo Japan

5. Department of Pediatric Hematology and Oncology Osaka City General Hospital Osaka Japan

6. Department of Pediatric Surgery Kyushu University Hospital Fukuoka Japan

7. Department of Anatomic Pathology Graduate School of Medical Sciences Kyushu University Fukuoka Japan

8. Department of Pediatrics Hokkaido University Sapporo Japan

9. Clinical Research Support Office National Cancer Center Hospital East Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14206

Reference52 articles.

1. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge

2. Epidemiological analysis of childhood cancer in Japan based on population-based cancer registries, 1993–2009

3. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

4. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

5. Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Cancer Therapy: The Role of KIF20A as a Target for Inhibitor Development and Immunotherapy;Cancers;2024-08-24

2. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment;Genes & Diseases;2024-03

3. FOXM1: A small fox that makes more tracks for cancer progression and metastasis;Seminars in Cancer Biology;2023-07

4. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors;Cells;2023-05-08

5. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer;Heliyon;2023-02